Salarius Pharmaceuticals, Inc.
Pharmaceutical Preparations · HOUSTON · TX
Moderate confidence (50%)
Updated Oct 16, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Salarius Pharmaceuticals, Inc. received a delisting notice from its exchange (Dec 31, 2025)
Timeline
Every material event, newest first. History is never overwritten.
Salarius Pharmaceuticals, Inc. received a delisting notice from its exchange
Dec 31, 2025
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 31, 2025, Salarius Pharmaceuticals, Inc. (the Company ) received written notice (the Notice ) from The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it is not in compliance with Nasdaq listing rule 5550(a)(2) because the closing bid price of the Company s common stock for the last 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the Minimum Bid Price Requirement ). Normally, a company would be afforded a 180…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker DCOY on Nasdaq.
- SEC CIK
- 0001615219
- Website
- —
- —
- Headquarters
- HOUSTON, TX
- Also known as
- Flex Pharma, Inc., Salarius Pharmaceuticals, Inc.
- Legal entities
- Salarius Pharmaceuticals, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Decoy Therapeutics Inc. — Pharmaceutical Preparations (SIC 2834) — HOUSTON, TX
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On December 31, 2025, Salarius Pharmaceuticals, Inc. (the Company ) received written notice (the Notice ) from The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that it is not in compliance with Nasdaq listing rule 5550(a)(2) because the closing bid price of the Company s common stock for the last 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the Minimum Bid Price Requirement ). Normally, a company would be afforded a 180…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.